Posted by Michael Wonder on 24 Jun 2025
Australians with cystic fibrosis benefit from life changing expanded listing
24 June 2025 - More Australians living with cystic fibrosis will have affordable access to a life changing treatment option under the PBS from 1 July 2025.
The PBS listing for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) will be expanded to include cystic fibrosis patients who have at least one cystic fibrosis transmembrane conductance regulator gene mutation that is responsive to treatment.
